# Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/does-oncotype-dx-recurrence-score-affect-the-management-of-patients-with-early/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Juhi Asad,Allyson F. Jacobson,Alison Estabrook,Sharon R. Smith,Susan K. Boolbol,Sheldon Feldman,Michael P. Osborne,Kwadwo Boachie‐Adjei,Wendy Twardzik,Paul Ian Tartter |
| Citations | 122 |
| DOI | 10.1016/j.amjsurg.2008.06.021 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1964793240 |
| PMID | 18809056 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Sheldon Feldman](https://scholariq.org/researchers/sheldon-feldman/)

## Paper journal

- [The American Journal of Surgery](https://scholariq.org/journals/the-american-journal-of-surgery/)

## Paper primary topic

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Paper topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Research and Treatment](https://scholariq.org/topics/cancer-research-and-treatment/)
- [Cancer Risks and Factors](https://scholariq.org/topics/cancer-risks-and-factors/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.